Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria

NCT00529867 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

267

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria, Falciparum

Interventions

DRUG: Artemether/lumefantrine tablets
DRUG: Artemether/Lumefantrine suspension

Sponsor

Dafra Pharma

Collaborators

[object Object]